Medicine
-
Liver Supplements With Milk Thistle, Turmeric and Dandelion Root Go Mainstream, With Caveats
Milk thistle used to be something you found only in dusty health food stores, sold in brown glass bottles to people who…
-
Merck and Moderna Report Phase 3 Win for mRNA Melanoma Therapy Plus Keytruda
New York, August 20 — Merck and Moderna announced successful results from a late-stage clinical trial for an mRNA-based cancer vaccine targeting…
-
Zelig Eshhar’s 1989 CAR Idea and CRISPR Therapeutics’ Off-the-Shelf Zugo-cel Lymphoma Results
BOSTON, July 14 — A new chapter in the fight against cancer is unfolding, and it involves editing a patient’s own immune…
-
Fenfluramine: From Fen-Phen scandal to seizure drug
NEW YORK, July 22 — Fenfluramine is back on the American market, a comeback twenty-three years in the making. The same drug…
-
Bedford Artist, 21, Dies of Glioblastoma Weeks After First CT Scan Showed Nothing
WASHINGTON, July 17 — Tyler Morton’s first CT scan did not show the brain lesion that later appeared on a second CT…
-
Frederick Banting: Co-Discoverer of Insulin, Nobel Laureate
TORONTO, July 16 — Frederick Banting died in a plane crash in Newfoundland in 1941, but the insulin he helped drag out…
-
Multi-cancer blood tests show early promise, but doctors want proof they work
ROME, July 16 — The shift is happening in plain sight. Cancer detection is moving from single-organ biopsies to a single blood…
-
Ernexa Moves ERNA-101 Into GMP Manufacturing Ahead of Planned IND Filing
KARACHI, July 15 — Ernexa Therapeutics is moving toward a planned first-in-human Phase 1 study for its lead cancer candidate, ERNA-101, though…
-
ERNA-101 Platform Targets Cancer with Differentiated Therapy
NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…
-
New Alzheimer’s Drug Kisunla Carries Significant Brain Risk Factors
The U.S. Food and Drug Administration approved Eli Lilly’s monoclonal antibody donanemab, marketed as Kisunla, on July 15, 2024. The drug is…
-
How Vaccines Train the Immune System and Cut Deaths from Disease
ASTANA, July 14 — The global vaccine market, a sector that directly shapes public health outcomes from Central Asia to the Americas,…
-
Innate vs. Adaptive Immunity: Two-Layered Defense System
MANILA, July 14 — For families across Asia, the idea of being protected from a disease long after recovery is something many…
-
Next-Generation CAR T-Cell Therapies Aim at Solid Tumors and Off-the-Shelf Donor Cells
SAN FRANCISCO, July 14 — The next generation of cancer immunotherapy is racing toward a milestone that could change how thousands of…
-
Geneticist Nir Barzilai’s TAME Metformin Aging Trial Still Waits for Funding
NEW YORK, July 14 — The figure that matters: 200. That is the number of peer-reviewed papers Dr. Nir Barzilai has published…
-
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
-
James Allison’s CTLA-4 Discovery Pioneered Cancer Checkpoint Therapy
HOUSTON, July 14 — The technical reality of cancer immunotherapy is that the body’s own T cells often have the means to…
-
Vaccine Development Timeline: From 1796 to mRNA in 2020
ROME, July 14 — For families, the story of vaccines is not a dry list of dates and laboratories. It is the…
-
How Joseph Meister Became the First Person Given Pasteur’s Rabies Vaccine
PARIS, July 14 — One hundred and thirty-nine years after a nine-year-old boy became the first human to survive a rabies infection…
-
Dr. Colin Haile leads UH fight against fentanyl with vaccine
HOUSTON, July 13 — A vaccine candidate designed to neutralise fentanyl and its illicit chemical cousins has cleared an early scientific hurdle,…
-
Study Finds Wealth and Air Pollution Are the Strongest Predictors of State Autism Rates
ATLANTA, July 13 — A fresh analysis of autism prevalence across American states has turned up a correlation that researchers say merits…
-
Experimental vaccine protects mice against fentanyl and related opioids in new study
HOUSTON, July 13 — On the ground in the fight against the opioid crisis, researchers at the University of Houston and the…
-
NYU AI Test Edges Out Oncotype DX in Predicting Breast Cancer Recurrence
NEW YORK, July 12 — A new AI tool from New York University may offer a cheaper alternative to genomic tests for…
-
Only 43 Antibiotics in Development as WHO Warns the Pipeline Falls Short
SINGAPORE, July 11 — For communities across Asia, the medicines that treat common infections are something many families take for granted. But…
-
Antimicrobial resistance killed 1.27 million people in 2019, Lancet study finds
MANILA, July 11 — Antimicrobial resistance, or AMR, is not a distant laboratory concern. For communities across Asia, it is a threat…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992